These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1075 related items for PubMed ID: 16368445

  • 1. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ.
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [Abstract] [Full Text] [Related]

  • 2. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU.
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [Abstract] [Full Text] [Related]

  • 3. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG.
    N Engl J Med; 2004 Apr 08; 350(15):1516-25. PubMed ID: 15071126
    [Abstract] [Full Text] [Related]

  • 4. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
    Drüeke TB.
    Ther Apher Dial; 2008 Oct 08; 12 Suppl 1():S2-12. PubMed ID: 19032522
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
    Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA.
    Am J Kidney Dis; 2009 Feb 08; 53(2):197-207. PubMed ID: 19110359
    [Abstract] [Full Text] [Related]

  • 6. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.
    Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW.
    J Am Soc Nephrol; 2005 Mar 08; 16(3):800-7. PubMed ID: 15689407
    [Abstract] [Full Text] [Related]

  • 7. New strategies for the treatment of hyperparathyroidism incorporating calcimimetics.
    de Francisco AL.
    Expert Opin Pharmacother; 2008 Apr 08; 9(5):795-811. PubMed ID: 18345956
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
    Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM.
    Nephrol Dial Transplant; 2005 Oct 08; 20(10):2186-93. PubMed ID: 16030053
    [Abstract] [Full Text] [Related]

  • 9. Cinacalcet: new drug. Secondary hyperparathyroidism: where are the clinical data?
    Prescrire Int; 2006 Jun 08; 15(83):90-3. PubMed ID: 16764095
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience with cinacalcet HCl.
    Ureña Torres P.
    Nephrol Dial Transplant; 2004 Aug 08; 19 Suppl 5():V27-33. PubMed ID: 15284357
    [Abstract] [Full Text] [Related]

  • 11. Drug Insight: renal indications of calcimimetics.
    Shahapuni I, Monge M, Oprisiu R, Mazouz H, Westeel PF, Morinière P, Massy Z, Choukroun G, Fournier A.
    Nat Clin Pract Nephrol; 2006 Jun 08; 2(6):316-25. PubMed ID: 16932453
    [Abstract] [Full Text] [Related]

  • 12. The role of cinacalcet in treating secondary hyperparathyroidism.
    Brommage D, Gallgano C.
    Nephrol Nurs J; 2005 Jun 08; 32(2):229-31. PubMed ID: 15889812
    [Abstract] [Full Text] [Related]

  • 13. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
    Shireman TI, Almehmi A, Wetmore JB, Lu J, Pregenzer M, Quarles LD.
    Am J Kidney Dis; 2010 Dec 08; 56(6):1108-16. PubMed ID: 20951487
    [Abstract] [Full Text] [Related]

  • 14. Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.
    Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Saha H, Ryba M, Bencova V, Baños A, Zani V, Fouque D.
    Nephrol Dial Transplant; 2009 Sep 08; 24(9):2852-9. PubMed ID: 19369690
    [Abstract] [Full Text] [Related]

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 08; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 16. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
    Paschoalin RP, Torregrosa JV, Sánchez-Escuredo A, Barros X, Durán CE, Campistol JM.
    Transplant Proc; 2012 Nov 08; 44(9):2588-9. PubMed ID: 23146463
    [Abstract] [Full Text] [Related]

  • 17. The role of calcimimetics in the treatment of hyperparathyroidism.
    Wüthrich RP, Martin D, Bilezikian JP.
    Eur J Clin Invest; 2007 Dec 08; 37(12):915-22. PubMed ID: 18036025
    [Abstract] [Full Text] [Related]

  • 18. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
    Quarles LD, Sherrard DJ, Adler S, Rosansky SJ, McCary LC, Liu W, Turner SA, Bushinsky DA.
    J Am Soc Nephrol; 2003 Mar 08; 14(3):575-83. PubMed ID: 12595492
    [Abstract] [Full Text] [Related]

  • 19. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2010 Jan 08; 21(1):93-101. PubMed ID: 20061700
    [Abstract] [Full Text] [Related]

  • 20. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
    Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2014 Jan 08; 2014(12):CD006254. PubMed ID: 25490118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.